• 
  Pierre Bay, Étienne Audureau, Sébastien Préau, Raphael Favory, Aurélie Guigon, et al.. COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants. Annals of Intensive Care, 2024, 14 (1), pp.65. ⟨10.1186/s13613-024-01296-0⟩. ⟨hal-04577615⟩
• 
  Jordan Scheer, Taylor Leroy, Sylvie Guillo, Florence Tubach, Antoine Rozes, et al.. Evolution of public funding since primary care research was considered as a priority research domain in france. BMC Primary Care, 2024, 25 (1), pp.142. ⟨10.1186/s12875-024-02384-7⟩. ⟨hal-04577368⟩
• 
  Nicolas de Prost, Etienne Audureau, Nicholas Heming, Elyanne Gault, Tài Pham, et al.. Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19. Nature Communications, 2022, 13 (1), pp.7547. ⟨10.1038/s41467-022-34575-0⟩. ⟨hal-04073916⟩
• 
  Paul Gougis, Anne-Sophie Hamy, Floriane Jochum, Kevin Bihan, Marie Carbonnel, et al.. Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and Newborns. JAMA Network Open, 2024, 7 (4), pp.e245625. ⟨10.1001/jamanetworkopen.2024.5625⟩. ⟨hal-04573116⟩
• 
  Paul Gougis, Floriane Jochum, Baptiste Abbar, Elise Dumas, Kevin Bihan, et al.. Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective. EClinicalMedicine, 2024, 70, pp.102536. ⟨10.1016/j.eclinm.2024.102536⟩. ⟨hal-04572045⟩
• 
  Vincent Bansaye, Pierre-Yves Boëlle, Simon Cauchemez, Bernard Cazelles, Pascal Crepey, et al.. Hommage à Elisabeta Vergu. 2024. ⟨hal-04230307v3⟩
• 
  Oumarou Nabi, Nathanaël Lapidus, Jerome Boursier, Philippe Mathurin, Victor de Ledinghen, et al.. Hepatitis C and NAFLD as Main Causes of Liver-Related Morbidity and Mortality in the French General Population: A Nationwide Study (NASH-CO Study). SSRN Electronic Journal, 2022, ⟨10.2139/ssrn.4161708⟩. ⟨hal-04566601⟩
• 
  Cédric Sueur, Giovanna Fancello, Alexandre Naud, Yan Kestens, Basile Chaix. The Complexity of Social Networks in Healthy Aging: Novel Metrics and Their Associations with Psychological Well-Being. Peer Community Journal, 2024, 4, pp.e23. ⟨10.24072/pcjournal.388⟩. ⟨hal-04565549⟩
• 
  Andrea Montanari, Limin Wang, Amit Birenboim, Basile Chaix. Urban environment influences on stress, autonomic reactivity and circadian rhythm: protocol for an ambulatory study of mental health and sleep. Frontiers in Public Health, 2024, 12, ⟨10.3389/fpubh.2024.1175109⟩. ⟨hal-04565083⟩
• 
  Simon Décary, Maarten de Wit, Florian Naye, Jennifer Barton, Liana Fraenkel, et al.. Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials. Seminars in Arthritis and Rheumatism, 2024, 65, pp.152381. ⟨10.1016/j.semarthrit.2024.152381⟩. ⟨hal-04564112⟩
• 
  Alessia Alunno, Francesco Carubbi, Javier Rodríguez-Carrio, Laure Gossec, Siobhán Donohoe, et al.. The management of cardiovascular risk in psoriatic disease: a bridge over troubled water. Seminars in Arthritis and Rheumatism, 2024, 65, pp.152389. ⟨10.1016/j.semarthrit.2024.152389⟩. ⟨hal-04564126⟩
• 
  Elisabetta Chessa, Alberto Floris, Mattia Congia, Maria Maddalena Angioni, Matteo Piga, et al.. Psychometric Properties of Patient Global Assessment in Psoriatic Arthritis: A Systematic Literature Review. Journal of Rheumatology, 2024, pp.jrheum.2023-0722. ⟨10.3899/jrheum.2023-0722⟩. ⟨hal-04564130⟩
• 
  Adeline Ruyssen-Witrand, Damien Caillet-Portillo, Aurélie Najm, Olivier Fogel, Athan Baillet, et al.. Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative. Joint Bone Spine, 2024, 91 (5), pp.105733. ⟨10.1016/j.jbspin.2024.105733⟩. ⟨hal-04564488⟩
• 
  David Saadoun, Matheus Vieira, Mathieu Vautier, Xenofon Baraliakos, Ioana Andreica, et al.. SARS-CoV-2 Outbreak in Immune-Mediated Inflammatory Diseases: The Euro-COVIMID Multicentre Cross-Sectional Study. The Lancet Rheumatology, 2021, 3 (7), pp.e481-e488. ⟨10.1016/S2665-9913(21)00112-0⟩. ⟨hal-03879106⟩
• 
  Milena A Gianfrancesco, Kimme L Hyrich, Laure Gossec, Anja Strangfeld, Loreto Carmona, et al.. Rheumatic Disease and COVID-19: Initial Data from the COVID-19 Global Rheumatology Alliance Provider Registries. The Lancet Rheumatology, 2020, 2 (5), pp.e250-e253. ⟨10.1016/S2665-9913(20)30095-3⟩. ⟨hal-03849960⟩
• 
  Philip Mease, Arthur Kavanaugh, Dafna Gladman, Oliver Fitzgerald, Enrique R. Soriano, et al.. Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials. Rheumatology and Therapy, 2022, 9 (4), pp.1181--1191. ⟨10.1007/s40744-022-00449-6⟩. ⟨hal-03896058⟩
• 
  Pedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, Elsa F Mateus, Kimme L Hyrich, et al.. Safety of Vaccination against SARS-CoV-2 in People with Rheumatic and Musculoskeletal Diseases: Results from the EULAR Coronavirus Vaccine (COVAX) Physician-Reported Registry. Annals of the Rheumatic Diseases, 2022, 81 (5), pp.695--709. ⟨10.1136/annrheumdis-2021-221490⟩. ⟨hal-03896047⟩
• 
  Josef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, Gerd R Burmester, Maxime Dougados, et al.. EULAR Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease-Modifying Antirheumatic Drugs: 2019 Update. Annals of the Rheumatic Diseases, 2020, 79 (6), pp.685--699. ⟨10.1136/annrheumdis-2019-216655⟩. ⟨hal-03895158⟩
• 
  Robert B M Landewé, Féline P B Kroon, Alessia Alunno, Aurélie Najm, Johannes Wj Bijlsma, et al.. EULAR Recommendations for the Management and Vaccination of People with Rheumatic and Musculoskeletal Diseases in the Context of SARS-CoV-2: The November 2021 Update. Annals of the Rheumatic Diseases, 2022, pp.annrheumdis-2021-222006. ⟨10.1136/annrheumdis-2021-222006⟩. ⟨hal-03894183⟩
• 
  Pil Højgaard, Louise Klokker, Ana-Maria Orbai, Kim Holmsted, Else M. Bartels, et al.. A Systematic Review of Measurement Properties of Patient Reported Outcome Measures in Psoriatic Arthritis: A GRAPPA-OMERACT Initiative. Seminars in Arthritis and Rheumatism, 2018, 47 (5), pp.654--665. ⟨10.1016/j.semarthrit.2017.09.002⟩. ⟨hal-03888153⟩

2 183

1 179